|
|
Volumn 370, Issue 18, 2014, Pages 1768-
|
|
Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BARDOXOLONE METHYL;
TRANSCRIPTION FACTOR NRF2;
DRUG DERIVATIVE;
OLEANOLIC ACID;
CHRONIC KIDNEY DISEASE;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
LETTER;
MEDICINE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
TREATMENT FAILURE;
CARDIOVASCULAR DISEASE;
CHRONIC KIDNEY FAILURE;
DIABETIC NEPHROPATHY;
FEMALE;
MALE;
MORTALITY;
NOTE;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
FEMALE;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MALE;
OLEANOLIC ACID;
RENAL INSUFFICIENCY, CHRONIC;
|
|
EID: 84899735524
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1400872 Document Type: Letter |
|
Times cited : (12)
|
|
References (1)
|
